Dr. Reddy's Laboratories ... (RDY)

NYSE: RDY · Real-Time Price · USD

13.85

-0.07 (-0.50%)

At close: May 01, 2025, 3:59 PM

13.90

0.40%

Pre-market: May 02, 2025, 07:50 AM EDT

Dr. Reddy's Laboratories Balance Sheet Statement

Financials in INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	7.11B	5.78B	14.85B	14.83B	2.05B	2.23B	2.64B	18.14B	39.95B
Short-Term Investments	74.36B	60.97B	29.51B	19.74B	23.69B	22.53B	18.33B	14.27B	35.03B
Long-Term Investments	5.25B	6.09B	7.99B	8.33B	3.09B	3.34B	4.65B	6.84B	3.3B
Other Long-Term Assets	16.12B	12.71B	948M	952M	2.58B	1.06B	1.2B	1.19B	1.06B
Receivables	80.3B	72.48B	66.76B	49.64B	50.28B	39.87B	40.62B	38.06B	41.31B
Inventory	63.55B	48.67B	50.88B	45.41B	35.07B	33.58B	29.09B	28.53B	25.58B
Other Current Assets	20.78B	19.85B	18.7B	17.48B	18.34B	15.35B	18.21B	14.93B	12.17B
Total Current Assets	248.05B	204.25B	181.11B	148.25B	130.37B	114.5B	109.64B	100.38B	119.69B
Property-Plant & Equipment	76.89B	56.54B	62.17B	57.11B	52.33B	54.09B	57.87B	57.16B	53.96B
Goodwill & Intangibles	41.2B	36.2B	31.66B	40.22B	31.65B	48.27B	48.61B	48.68B	24.64B
Total Long-Term Assets	139.47B	118.6B	115.55B	117.24B	101.87B	110.93B	115.96B	119.45B	87.96B
Total Assets	387.52B	322.85B	296.65B	265.49B	232.24B	225.43B	225.6B	219.82B	207.65B
Account Payables	21.55B	17.86B	15.97B	12.7B	10.74B	10.3B	9.21B	n/a	n/a
Deferred Revenue	n/a	1.98B	2.58B	2.03B	1.91B	1.35B	982M	819M	659M
Short-Term Debt	12.72B	11.19B	27.08B	23.14B	20.32B	16.32B	25.56B	43.74B	22.72B
Other Current Liabilities	19.97B	16.95B	17.69B	14.88B	12.82B	9.21B	11.04B	8.91B	10.91B
Total Current Liabilities	96.04B	85.72B	97.84B	81.47B	72.81B	59.7B	69.69B	85B	64.65B
Long-Term Debt	3.8B	n/a	3.8B	3.8B	n/a	21.45B	24.46B	4.85B	9.94B
Other Long-Term Liabilities	4.94B	2.99B	2.54B	2.4B	3.13B	3.53B	4.36B	5.33B	3.98B
Total Long-Term Liabilities	10.93B	4.27B	8.29B	9.04B	4.44B	25.53B	29.45B	10.78B	14.67B
Total Liabilities	106.97B	89.99B	106.13B	90.51B	77.25B	85.23B	99.14B	95.78B	79.31B
Total Debt	20.02B	13.47B	33.84B	30.31B	22.1B	38.38B	50.71B	49.19B	33.51B
Common Stock	834M	833M	832M	832M	831M	830M	830M	829M	853M
Retained Earnings	265.26B	215.59B	175.71B	157.93B	144.25B	128.65B	113.86B	108.22B	99.55B
Comprehensive Income	4.03B	1.27B	1.06B	1.33B	2.42B	3.04B	3.98B	7.8B	5.33B
Shareholders Equity	280.55B	232.86B	190.53B	174.98B	154.99B	140.2B	126.46B	124.04B	128.34B
Total Investments	79.62B	67.06B	37.5B	28.08B	26.78B	25.87B	22.98B	21.11B	38.33B